IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 4725 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1415    
    Printed109    
    Emailed0    
    PDF Downloaded79    
    Comments [Add]    

Recommend this journal

 

 RESEARCH PAPER
Year : 1991  |  Volume : 23  |  Issue : 3  |  Page : 132-136

Antipyrine half-life in rabbits given long-term anti-tubercular therapy



Correspondence Address:
R Malhi


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

1. Pharmacokinetics of Antipyrine (AP), (Single oral dose, 20 mg/kg) was studied during long-term treatment with anti-tubercular therapy. 2. Anti-tubercular therapy (ATT) with two main-line drugs i.e. Rifampin (RLF) and Isoniazid (INH) was given over a period of 45 days. AP was measured on 0, 25 and 50th day of the treatment. 3. In controls (without ATT) there was no significant difference observed at 0, 25 and 50th day in the mean plasma concentration, t1/2, Cl, Kel and AUCO 0-( 4. In test group, the mean plasma concentration was significantly decreased on the 25th day as compared to the 0 day level. 5. The Plasma half-life, clearance, elimination rate constant area under the plasma concentration time curve was found to be statistically significant on 25th day as compared to 0 day levels. No significant difference was observed between 25th and 50th day.






[PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow